2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$596.48+$0.82 (+0.14%)
Price as of Nov 12, 2026 8:59 AM EST- $25.4BMarket Cap
- 29.06%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$596.48+$0.82 (+0.14%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $595.66 | ||
Change | +$7.05 (+1.20%) | ||
Open | $588.36 | ||
High | $598.80 | ||
Low | $583.80 | ||
Previous Close | $588.61 | ||
Volume | 369,302 | ||
30-Day Average Volume | 574,818 | ||
1-Week Change | -2.11% | ||
1-Month Change | 8.47% | ||
1-Year Change | 29.06% | ||
3-Year Change | 167.30% | ||
5-Year Change | 196.50% | ||
Fundamentals | |||
Shares Outstanding | 42.6M | ||
Total Assets | $7.0B | ||
Market Cap | $25.4B | ||
Enterprise Value | $24.4B | ||
Period: QTR TTM FY | |||
Revenue | $832.5M | ||
Net Income | $258.6M | ||
Free Cash Flow | $125.8M | ||
EBIT | $372.8M | ||
EBITDA | $399.2M | ||
Net Working Capital | $2.3B | ||
EPS | $5.71 | ||
Enterprise Value/EBITDA | 61 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 4 | ||
P/E | 104 | ||
PEG | -5 | ||
Price/Free Cash Flow | 202 | ||
Price/Operating Cash Flow | 83 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 09/23/2009 | ||
Earnings & Revenue